TPO and non-small cell lung carcinoma: As shown in Table 1, TPO expression was also positively correlated with clinicopathological parameters of NSCLC patients, including differentiation (P = 0.015), P‐TNM stage (P < 0.01), lymph node metastasis (P < 0.01) and tumour size (P < 0.01).